Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7298 p562
8 May 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Meta-analysis shows vitamin D reduces falls

Vitamin D supplementation may reduce the risk of falls in older people by more than 20 per cent, according to a new meta-analysis published last week.

The analysis included five randomised, controlled trials involving 1,237 participants in stable health, with a mean age of 60 years. Based on these studies, the authors found that vitamin D reduced the odds ratio of falling by 22 per cent compared with patients receiving calcium or placebo. The number needed to treat (NNT) for a beneficial effect to be observed was 15.

Subgroup analysis indicated that the effect size was independent of patient gender, calcium supplementation, type of vitamin D and duration of therapy.

The authors state: “Given the NNT of 15 and the high morbidity, mortality and economic cost of falls, our results are sufficiently compelling to consider vitamin D supplementation for elderly individuals.” They add that further studies examining the effect of alternative types of vitamin D and their doses, the role of calcium supplementation and effects in men should be considered.

The authors explain that the active metabolite of vitamin D binds to a highly specific receptor in muscle tissue which appears to lead to improved muscle function. Studies had shown that this effect improved body sway and, with calcium, increased musculoskeletal function in elderly women (JAMA 2004;291:1999).

Back to Top


©The Pharmaceutical Journal